{
    "organizations": [],
    "uuid": "e45d89b7400b4d4c39cbab0a45969ce4a178b6fb",
    "author": "",
    "url": "https://www.reuters.com/article/aurka-pharma-ma-lilly/eli-lilly-to-buy-cancer-drug-developer-aurka-pharma-idUSL3N1SL4PI",
    "ord_in_thread": 0,
    "title": "Eli Lilly to buy cancer drug developer AurKa Pharma",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14, 2018 / 11:53 AM / in 25 minutes Eli Lilly to buy cancer drug developer AurKa Pharma Reuters Staff 1 Min Read\nMay 14 (Reuters) - Drugmaker Eli Lilly and Co said on Monday it would buy AurKa Pharma Inc to get access to the privately-held companyâ€™s experimental cancer treatment for solid tumors.\nAurKa Pharma shareholders will get an upfront payment of $110 million and will be eligible to receive up to $465 million in regulatory and sales milestones, Eli Lilly said in a statement. Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur",
    "published": "2018-05-14T14:52:00.000+03:00",
    "crawled": "2018-05-14T15:20:07.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "eli",
        "lilly",
        "buy",
        "cancer",
        "drug",
        "developer",
        "aurka",
        "pharma",
        "reuters",
        "staff",
        "min",
        "read",
        "may",
        "reuters",
        "drugmaker",
        "eli",
        "lilly",
        "co",
        "said",
        "monday",
        "would",
        "buy",
        "aurka",
        "pharma",
        "inc",
        "get",
        "access",
        "company",
        "experimental",
        "cancer",
        "treatment",
        "solid",
        "tumor",
        "aurka",
        "pharma",
        "shareholder",
        "get",
        "upfront",
        "payment",
        "million",
        "eligible",
        "receive",
        "million",
        "regulatory",
        "sale",
        "milestone",
        "eli",
        "lilly",
        "said",
        "statement",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ]
}